Lobbying Information
Subject Matters
- Budget
- Economic Development
- Health
- Research and Development
- Science and Technology
Subject matters added through a monthly communication report
Subject Matter Details
Policies or Program
- Build awareness with decision makers on Attention Deficit Hyperactivity Disorder, the lack of broad-based screening, and advocate for the implementation of programs to improve diagnosis and support of those living with Attention Deficit Hyperactivity Disorder.
- Engaging with federal government officials on national pharmacare policy and implementation, and the development of a federal strategy for drugs for rare diseases.
Regulation
- Federal government relations and advocacy regarding regulations under the Patented Medicine Prices Review Board (and its impact to drugs for rare diseases).
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Correctional Service of Canada (CSC)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Safety Canada (PS)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
22 Adelaide Street West
Toronto, ON M5H 4E3
Canada
Telephone number:
647-798-2200
Web address:
https://www.takeda.com/en-ca/
Client representative
Rebecca Yu Vice President, Market Access and External Affairs
Parent Company Information
Takeda Canada Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Takeda Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Takeda Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Takeda Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Johnathan Rix
|
Public offices held
Business address:
1 Nicholas Street, Suite 414
Ottawa, ON K1N 7B7
Canada
Telephone number:
613-807-7198
Consultant Firm and Address
Firm:
Santis Health Inc.
Address:
1 Nicholas Street, Suite 414
Ottawa, ON K1N 7B7
Canada
Telephone number:
613-807-7198
